A detailed history of Putnam Investments LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 227,118 shares of PCVX stock, worth $20.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
227,118
Previous 106,413 113.43%
Holding current value
$20.4 Million
Previous $5.42 Million 162.96%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$45.35 - $63.41 $5.47 Million - $7.65 Million
120,705 Added 113.43%
227,118 $14.3 Million
Q3 2023

Nov 14, 2023

BUY
$46.0 - $53.1 $720,820 - $832,077
15,670 Added 17.27%
106,413 $5.42 Million
Q2 2023

Aug 14, 2023

BUY
$34.66 - $54.07 $3.15 Million - $4.91 Million
90,743 New
90,743 $4.53 Million

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.34B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.